tiprankstipranks
DaVita (GB:0I7E)
LSE:0I7E
UK Market

DaVita Stock Analysis & Ratings

GB:0I7E Stock Chart & Stats

Day’s Range$97.13 - $100.98
52-Week Range$0.00 - $0.00
Previous Close$98.86
Volume1.00
Average Volume (3M)181.00
Market Cap$9.21B
P/E Ratio11.8
Beta1.05
Next EarningsAug 02, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score8
EPS (TTM)8.40


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

GB:0I7E FAQ

What was DaVita’s price range in the past 12 months?
DaVita lowest stock price was $0.00 and its highest was $0.00 in the past 12 months.
    What is DaVita’s market cap?
    DaVita’s market cap is $9.21B.
      What is DaVita’s price target?
      The average price target for DaVita is $124.33. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $150.00 ,the lowest forecast is $110.00. The average price target represents 27.65% Increase from the current price of $97.4.
        What do analysts say about DaVita?
        DaVita’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is DaVita’s upcoming earnings report date?
          DaVita’s upcoming earnings report date is Aug 02, 2022 which is in 76 days.
            How were DaVita’s earnings last quarter?
            DaVita released its earnings results on May 05, 2022. The company reported $1.61 earnings per share for the quarter, missing the consensus estimate of $1.867 by -$0.257.
              Is DaVita overvalued?
              According to Wall Street analysts DaVita’s price is currently Undervalued.
                Does DaVita pay dividends?
                DaVita does not currently pay dividends.
                What is DaVita’s EPS estimate?
                DaVita’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does DaVita have?
                DaVita has 94,600,000 shares outstanding.
                  What happened to DaVita’s price movement after its last earnings report?
                  DaVita reported an EPS of $1.61 in its last earnings report, missing expectations of $1.867. Following the earnings report the stock price went down -4.657%.
                    Which hedge fund is a major shareholder of DaVita?
                    Among the largest hedge funds holding DaVita’s share is Berkshire Hathaway Inc. It holds DaVita’s shares valued at 4B.

                      ---

                      DaVita Stock Analysis

                      Smart Score
                      8
                      Outperform
                      1
                      2
                      3
                      4
                      5
                      6
                      7
                      8
                      9
                      10
                      Price Target
                      $124.33
                      ▲(27.65% Upside)
                      Moderate Buy
                      The DaVita stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      DaVita

                      DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Fresenius Medical Care
                      Surgery Partners
                      Hanger Orthopedic
                      Tenet Healthcare

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis